Showing results (371-380 of 417) with videos related to

Sort By:
Pageof 42
Gastroenterology|August 12, 2019
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir TherapyAnna S Lok, Mark S Sulkowski, Jens J Kort, et al.
Annals of Internal Medicine|April 12, 2014
Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort studyVincent Lo Re, Michael J Kallan, Janet P Tate, et al.
Hepatology (Baltimore, Md.)|April 8, 2015
Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysisK Rajender Reddy, Marc Bourlière, Mark Sulkowski, et al.
Gastroenterology|August 4, 2016
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 TrialEric Lawitz, Nancy Reau, Federico Hinestrosa, et al.
Hepatology (Baltimore, Md.)|July 9, 2025
Salivary microbiome and serum metabolomics add to clinical biomarkers to predict 6-month hospitalizations in a multicenter cirrhosis outpatient cohortJasmohan S Bajaj, K Rajender Reddy, Puneeta Tandon, et al.
The Lancet. Gastroenterology & Hepatology|June 4, 2018
Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1Marc Bourlière, Stuart C Gordon, Eugene R Schiff, et al.
Open Forum Infectious Diseases|May 5, 2017
Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis StatusCharitha Gowda, Craig W Newcomb, Qing Liu, et al.
Gastroenterology|July 21, 2020
Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With CirrhosisJasmohan S Bajaj, K Rajender Reddy, Jacqueline G O'Leary, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Carbohydrate consumption drives adaptive mutations in Escherichia coli associated with increased risk for systemic infectionAaron L Hecht, Nadim Mahmud, Subhan Chaudhry, et al.
Hepatology (Baltimore, Md.)|April 20, 2018
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus InfectionNancy Reau, Paul Y Kwo, Susan Rhee, et al.
Pageof 42